Epilepsy Study Consortium Inc

Analysis

Epilepsy Study Consortium Inc is a registered charity in United States, based in Reston, VA. It received its IRS tax-exemption ruling in May 2007, 19 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Epilepsy Study Consortium Inc reported income of $3.4m and spending of $1.7m, leaving 50% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $2.0m to $3.4m (+70%), an average of +14% a year. The sharpest change came in the year to December 2023, when income rose by 58%. Over the whole period it spent 92% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Epilepsy Study Consortium Inc sits at the 76th percentile: it is larger than about 76% of them. Against every charity in United States with reported income it ranks in the 90th percentile, and in the 90th percentile within VA. Charities of a similar size with the same main cause include Collis P & Howard Huntington Memorial Hospital Trust ($3.4m), Pro-Action ($3.4m) and Make a Wish Foundation of Mississippi Chartered ($3.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 25% and program service revenue 73% of the total. Compensation of current officers, directors and key employees was $365k (21% of expenses). Other salaries and wages came to $348k. At year end it held assets of $3.5m against liabilities of $0, net assets of $3.5m. It reported 7 employees.